Olomouc, Czechia

Iva Truxova

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Iva Truxova: Innovator in Cancer Immunotherapy

Introduction

Iva Truxova is a notable inventor based in Olomouc, Czech Republic. She has made significant contributions to the field of cancer immunotherapy, holding a total of 4 patents. Her innovative work focuses on the cryopreservation of apoptotic cancer cells, which has the potential to enhance immunotherapy treatments.

Latest Patents

One of Iva Truxova's latest patents is titled "Cryopreservation of apoptotic cancer cells for use in immunotherapy against cancer." This patent describes a reliable method for preparing a potent vaccine useful for immunotherapy. The method involves cryopreserving a population of cells undergoing immunogenic cell death and using these cells to activate dendritic cells for immunotherapy. Specifically, the method includes cryopreserving cancer cells that are undergoing cell death, which can then be utilized to prepare a pharmaceutical composition for cancer immunotherapy.

Career Highlights

Iva Truxova has established herself as a key figure in her field through her innovative research and development efforts. Her work at Sotio A.s. has allowed her to focus on groundbreaking methods that could revolutionize cancer treatment.

Collaborations

Iva collaborates with talented individuals such as Jitka Fucikova and Lenka Koci, who contribute to her research endeavors. Their combined expertise enhances the potential impact of their work in the field of immunotherapy.

Conclusion

Iva Truxova's contributions to cancer immunotherapy through her innovative patents and collaborative efforts position her as a significant inventor in the medical field. Her work continues to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…